Interestingly, SVZ-GBM appeared to be more sensitive than TM-GBM to the targeting of FKBP51s, according to the PD-L1 down-expression, which was more powerful in SVZ-GBM than in TM-GBM cells (Fig. 4b). This evidence concerns the gene CD274 and glioblastoma.